var data={"name":"Rheumatoid arthritis","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Clinical manifestations","type":"SUBSECTION","items":[{"name":"Cervical subluxation in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cervical-subluxation-in-rheumatoid-arthritis"},{"name":"Clinical manifestations of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-of-rheumatoid-arthritis"},{"name":"Diagnosis and differential diagnosis of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-and-differential-diagnosis-of-rheumatoid-arthritis"},{"name":"Evaluation of the adult with polyarticular pain","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluation-of-the-adult-with-polyarticular-pain"},{"name":"Heart failure and left ventricular dysfunction in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=heart-failure-and-left-ventricular-dysfunction-in-rheumatoid-arthritis"},{"name":"Hematologic manifestations of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hematologic-manifestations-of-rheumatoid-arthritis"},{"name":"Interstitial lung disease in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=interstitial-lung-disease-in-rheumatoid-arthritis"},{"name":"Neurologic manifestations of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neurologic-manifestations-of-rheumatoid-arthritis"},{"name":"Ocular manifestations of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ocular-manifestations-of-rheumatoid-arthritis"},{"name":"Overview of the systemic and nonarticular manifestations of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-systemic-and-nonarticular-manifestations-of-rheumatoid-arthritis"},{"name":"Rheumatoid arthritis and pregnancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rheumatoid-arthritis-and-pregnancy"},{"name":"Rheumatoid nodules","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rheumatoid-nodules"},{"name":"Treatment of rheumatoid vasculitis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-rheumatoid-vasculitis"}]},{"name":"Diagnosis","type":"SUBSECTION","items":[{"name":"Acute phase reactants","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acute-phase-reactants"},{"name":"Biologic markers in the diagnosis and assessment of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=biologic-markers-in-the-diagnosis-and-assessment-of-rheumatoid-arthritis"},{"name":"Diagnosis and differential diagnosis of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-and-differential-diagnosis-of-rheumatoid-arthritis"},{"name":"Evaluation and medical management of end-stage rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluation-and-medical-management-of-end-stage-rheumatoid-arthritis"},{"name":"Evaluation of the adult with polyarticular pain","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluation-of-the-adult-with-polyarticular-pain"},{"name":"Investigational biologic markers in the diagnosis and assessment of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=investigational-biologic-markers-in-the-diagnosis-and-assessment-of-rheumatoid-arthritis"},{"name":"Overview of the systemic and nonarticular manifestations of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-systemic-and-nonarticular-manifestations-of-rheumatoid-arthritis"},{"name":"Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=undifferentiated-systemic-rheumatic-connective-tissue-diseases-and-overlap-syndromes"}]},{"name":"Diseases associated with RA","type":"SUBSECTION","items":[{"name":"Clinical manifestations and diagnosis of Felty's syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-feltys-syndrome"},{"name":"Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-presentation-laboratory-manifestations-and-diagnosis-of-immunoglobulin-light-chain-al-amyloidosis"},{"name":"Coronary artery disease in rheumatoid arthritis: Implications for prevention and management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=coronary-artery-disease-in-rheumatoid-arthritis-implications-for-prevention-and-management"},{"name":"Coronary artery disease in rheumatoid arthritis: Pathogenesis, risk factors, clinical manifestations, and diagnostic implications","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=coronary-artery-disease-in-rheumatoid-arthritis-pathogenesis-risk-factors-clinical-manifestations-and-diagnostic-implications"},{"name":"Large granular lymphocyte leukemia in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=large-granular-lymphocyte-leukemia-in-rheumatoid-arthritis"},{"name":"Ocular manifestations of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ocular-manifestations-of-rheumatoid-arthritis"},{"name":"Renal amyloidosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=renal-amyloidosis"},{"name":"Rheumatoid arthritis and pregnancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rheumatoid-arthritis-and-pregnancy"}]},{"name":"Juvenile arthritis","type":"SUBSECTION","items":[{"name":"Classification of juvenile arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=classification-of-juvenile-arthritis"},{"name":"Juvenile idiopathic arthritis: Epidemiology and immunopathogenesis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=juvenile-idiopathic-arthritis-epidemiology-and-immunopathogenesis"},{"name":"Oligoarticular juvenile idiopathic arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=oligoarticular-juvenile-idiopathic-arthritis"},{"name":"Polyarticular juvenile idiopathic arthritis: Clinical manifestations, diagnosis, and complications","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=polyarticular-juvenile-idiopathic-arthritis-clinical-manifestations-diagnosis-and-complications"},{"name":"Polyarticular juvenile idiopathic arthritis: Treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=polyarticular-juvenile-idiopathic-arthritis-treatment"},{"name":"Spondyloarthritis in children","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=spondyloarthritis-in-children"},{"name":"Systemic juvenile idiopathic arthritis: Clinical manifestations and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=systemic-juvenile-idiopathic-arthritis-clinical-manifestations-and-diagnosis"},{"name":"Systemic juvenile idiopathic arthritis: Course, prognosis, and complications","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=systemic-juvenile-idiopathic-arthritis-course-prognosis-and-complications"},{"name":"Systemic juvenile idiopathic arthritis: Treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=systemic-juvenile-idiopathic-arthritis-treatment"}]},{"name":"Pathogenesis","type":"SUBSECTION","items":[{"name":"Biologic markers in the diagnosis and assessment of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=biologic-markers-in-the-diagnosis-and-assessment-of-rheumatoid-arthritis"},{"name":"Epidemiology of, risk factors for, and possible causes of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-of-risk-factors-for-and-possible-causes-of-rheumatoid-arthritis"},{"name":"HLA and other susceptibility genes in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hla-and-other-susceptibility-genes-in-rheumatoid-arthritis"},{"name":"Origin and utility of measurement of rheumatoid factors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=origin-and-utility-of-measurement-of-rheumatoid-factors"},{"name":"Pathogenesis of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-rheumatoid-arthritis"},{"name":"Synovial pathology in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=synovial-pathology-in-rheumatoid-arthritis"}]},{"name":"Prognosis","type":"SUBSECTION","items":[{"name":"Disease outcome and functional capacity in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=disease-outcome-and-functional-capacity-in-rheumatoid-arthritis"},{"name":"Investigational biologic markers in the diagnosis and assessment of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=investigational-biologic-markers-in-the-diagnosis-and-assessment-of-rheumatoid-arthritis"}]},{"name":"Risk factors","type":"SUBSECTION","items":[{"name":"Epidemiology of, risk factors for, and possible causes of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-of-risk-factors-for-and-possible-causes-of-rheumatoid-arthritis"},{"name":"Origin and utility of measurement of rheumatoid factors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=origin-and-utility-of-measurement-of-rheumatoid-factors"},{"name":"Pathogenesis of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-rheumatoid-arthritis"}]},{"name":"Side effects of drugs used in RA","type":"SUBSECTION","items":[{"name":"Antimalarial drugs in the treatment of rheumatic disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antimalarial-drugs-in-the-treatment-of-rheumatic-disease"},{"name":"Aspirin: Mechanism of action, major toxicities, and use in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=aspirin-mechanism-of-action-major-toxicities-and-use-in-rheumatic-diseases"},{"name":"Drug-induced lung disease in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=drug-induced-lung-disease-in-rheumatoid-arthritis"},{"name":"Hepatotoxicity associated with chronic low-dose methotrexate for nonmalignant disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hepatotoxicity-associated-with-chronic-low-dose-methotrexate-for-nonmalignant-disease"},{"name":"Interstitial lung disease in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=interstitial-lung-disease-in-rheumatoid-arthritis"},{"name":"Major side effects of gold therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=major-side-effects-of-gold-therapy"},{"name":"Major side effects of low-dose methotrexate","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=major-side-effects-of-low-dose-methotrexate"},{"name":"Pharmacology and side effects of azathioprine when used in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-and-side-effects-of-azathioprine-when-used-in-rheumatic-diseases"},{"name":"Pharmacology of cyclosporine and tacrolimus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-of-cyclosporine-and-tacrolimus"},{"name":"Rituximab and other B cell targeted therapies for rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rituximab-and-other-b-cell-targeted-therapies-for-rheumatoid-arthritis"},{"name":"Sulfasalazine: Pharmacology, administration, and adverse effects in the treatment of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=sulfasalazine-pharmacology-administration-and-adverse-effects-in-the-treatment-of-rheumatoid-arthritis"},{"name":"T-cell targeted therapies for rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=t-cell-targeted-therapies-for-rheumatoid-arthritis"},{"name":"Use of glucocorticoids in the treatment of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-glucocorticoids-in-the-treatment-of-rheumatoid-arthritis"},{"name":"Use of gold compounds in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-gold-compounds-in-rheumatic-diseases"},{"name":"Use of methotrexate in the treatment of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-methotrexate-in-the-treatment-of-rheumatoid-arthritis"}]},{"name":"Treatment","type":"SUBSECTION","items":[{"name":"Alternatives to methotrexate for the initial treatment of rheumatoid arthritis in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=alternatives-to-methotrexate-for-the-initial-treatment-of-rheumatoid-arthritis-in-adults"},{"name":"Antimalarial drugs in the treatment of rheumatic disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antimalarial-drugs-in-the-treatment-of-rheumatic-disease"},{"name":"Aspirin: Mechanism of action, major toxicities, and use in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=aspirin-mechanism-of-action-major-toxicities-and-use-in-rheumatic-diseases"},{"name":"Assessment of rheumatoid arthritis activity in clinical trials and clinical practice","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=assessment-of-rheumatoid-arthritis-activity-in-clinical-trials-and-clinical-practice"},{"name":"Cervical subluxation in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cervical-subluxation-in-rheumatoid-arthritis"},{"name":"Clinical trials of combination therapy in persistently active rheumatoid arthritis in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-trials-of-combination-therapy-in-persistently-active-rheumatoid-arthritis-in-adults"},{"name":"Drug therapy in Felty's syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=drug-therapy-in-feltys-syndrome"},{"name":"Drug-induced lung disease in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=drug-induced-lung-disease-in-rheumatoid-arthritis"},{"name":"Evaluation and medical management of end-stage rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluation-and-medical-management-of-end-stage-rheumatoid-arthritis"},{"name":"General principles of management of rheumatoid arthritis in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-principles-of-management-of-rheumatoid-arthritis-in-adults"},{"name":"General principles of the use of cyclophosphamide in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-principles-of-the-use-of-cyclophosphamide-in-rheumatic-diseases"},{"name":"Hepatotoxicity associated with chronic low-dose methotrexate for nonmalignant disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hepatotoxicity-associated-with-chronic-low-dose-methotrexate-for-nonmalignant-disease"},{"name":"Initial treatment of rheumatoid arthritis in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=initial-treatment-of-rheumatoid-arthritis-in-adults"},{"name":"Major side effects of gold therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=major-side-effects-of-gold-therapy"},{"name":"Major side effects of low-dose methotrexate","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=major-side-effects-of-low-dose-methotrexate"},{"name":"Nonpharmacologic therapies and preventive measures for patients with rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nonpharmacologic-therapies-and-preventive-measures-for-patients-with-rheumatoid-arthritis"},{"name":"Overview of immunosuppressive and conventional (non-biologic) disease-modifying drugs in the rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-immunosuppressive-and-conventional-non-biologic-disease-modifying-drugs-in-the-rheumatic-diseases"},{"name":"Pharmacology and side effects of azathioprine when used in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-and-side-effects-of-azathioprine-when-used-in-rheumatic-diseases"},{"name":"Pharmacology of cyclosporine and tacrolimus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-of-cyclosporine-and-tacrolimus"},{"name":"Pharmacology, dosing, and adverse effects of leflunomide in the treatment of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-dosing-and-adverse-effects-of-leflunomide-in-the-treatment-of-rheumatoid-arthritis"},{"name":"Preoperative evaluation and perioperative management of patients with rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=preoperative-evaluation-and-perioperative-management-of-patients-with-rheumatic-diseases"},{"name":"Randomized clinical trials in rheumatoid arthritis of biologic agents that inhibit IL-1, IL-6, and RANKL","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=randomized-clinical-trials-in-rheumatoid-arthritis-of-biologic-agents-that-inhibit-il-1-il-6-and-rankl"},{"name":"Randomized clinical trials of combinations of nonbiologic DMARDs in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=randomized-clinical-trials-of-combinations-of-nonbiologic-dmards-in-rheumatoid-arthritis"},{"name":"Randomized clinical trials of tumor necrosis factor inhibitors in rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=randomized-clinical-trials-of-tumor-necrosis-factor-inhibitors-in-rheumatoid-arthritis"},{"name":"Rituximab and other B cell targeted therapies for rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rituximab-and-other-b-cell-targeted-therapies-for-rheumatoid-arthritis"},{"name":"Role of splenectomy for Felty's syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=role-of-splenectomy-for-feltys-syndrome"},{"name":"Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=sulfasalazine-and-5-aminosalicylates-in-the-treatment-of-inflammatory-bowel-disease"},{"name":"Sulfasalazine: Pharmacology, administration, and adverse effects in the treatment of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=sulfasalazine-pharmacology-administration-and-adverse-effects-in-the-treatment-of-rheumatoid-arthritis"},{"name":"T-cell targeted therapies for rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=t-cell-targeted-therapies-for-rheumatoid-arthritis"},{"name":"Total joint replacement for severe rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=total-joint-replacement-for-severe-rheumatoid-arthritis"},{"name":"Treatment of rheumatoid arthritis in adults resistant to initial biologic DMARD therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-rheumatoid-arthritis-in-adults-resistant-to-initial-biologic-dmard-therapy"},{"name":"Treatment of rheumatoid arthritis in adults resistant to initial nonbiologic DMARD therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-rheumatoid-arthritis-in-adults-resistant-to-initial-nonbiologic-dmard-therapy"},{"name":"Treatment of rheumatoid vasculitis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-rheumatoid-vasculitis"},{"name":"Undifferentiated early inflammatory arthritis in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=undifferentiated-early-inflammatory-arthritis-in-adults"},{"name":"Use of glucocorticoids in the treatment of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-glucocorticoids-in-the-treatment-of-rheumatoid-arthritis"},{"name":"Use of gold compounds in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-gold-compounds-in-rheumatic-diseases"},{"name":"Use of methotrexate in the treatment of rheumatoid arthritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-methotrexate-in-the-treatment-of-rheumatoid-arthritis"}]}]}